Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.
about
Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived BiomarkersCirculating tumor DNA: a promising biomarker in the liquid biopsy of cancerCirculating tumor DNA in hepatocellular carcinoma: trends and challengesFragment Length of Circulating Tumor DNASingle-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasmaOrigins, structures, and functions of circulating DNA in oncologyCirculating Tumor DNA as Biomarkers for Cancer Detection.Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer TypesThe feasibility of using mutation detection in ctDNA to assess tumor dynamics.Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC)Circulating tumor-derived DNA is shorter than somatic DNA in plasma.Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients.Very Short Mitochondrial DNA Fragments and Heteroplasmy in Human Plasma.Cell-Free DNA Provides a Good Representation of the Tumor Genome Despite Its Biased Fragmentation Patterns.Emerging concepts in liquid biopsiesNon-random fragmentation patterns in circulating cell-free DNA reflect epigenetic regulation.Aberrant reduction of telomere repetitive sequences in plasma cell-free DNA for early breast cancer detection.Novel insights into Notum and glypicans regulation in colorectal cancerMutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patientsPlasma Circulating Cell-free DNA Integrity as a Promising Biomarker for Diagnosis and Surveillance in Patients with Hepatocellular Carcinoma.Liquid Biopsies for Cancer: Coming to a Patient near You.Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management.KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-controlCancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA.The impact of digital DNA counting technologies on noninvasive prenatal testing.The liquid biopsy in lung cancerLiquid biopsies come of age: towards implementation of circulating tumour DNA.Integrating liquid biopsies into the management of cancer.An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence.Facile single-stranded DNA sequencing of human plasma DNA via thermostable group II intron reverse transcriptase template switching.Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits.Collection of cell-free DNA for genomic analysis of solid tumors in a clinical laboratory setting.Characterization of the release and biological significance of cell-free DNA from breast cancer cell linesCons: Can liquid biopsy replace tissue biopsy?-the US experience.Characterisation of the changing genomic landscape of metastatic melanoma using cell free DNA.Liquid biopsy in colon cancer: comparison of different circulating DNA extraction systems following absolute quantification of KRAS mutations using Intplex allele-specific PCR.Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy.Incorporating Blood-based Liquid Biopsy Information into Cancer Staging: Time for a TNMB System?
P2860
Q26741204-00BA0533-FFBD-48B4-A239-BB0C800BB6ADQ26746010-5B957696-5F4D-4CE2-9037-33FE1D9FAD01Q26749417-B2FC9366-1BB1-489F-BF7D-8F5C59C750F1Q27308628-4F982F09-5A3D-46D2-95ED-8F3DEBCDC6A1Q28601304-8C8CAF43-47B7-4589-A233-D007313B1ED8Q30249103-FF328F30-8ACF-4E9D-990A-867ED37D48C7Q33632125-0E3F3332-5EFE-434C-84BC-C862CBC467C5Q33673752-1DCCA668-5DA2-4467-A95E-F1E34C7F7F12Q33697983-AE5FB0A0-339B-43B4-9A26-C6914C5E629CQ34515855-CAA167FA-81B0-476D-8950-AB78CC76BA56Q35212453-E39149DB-7C2A-4D8D-847A-BAFB5BF313AFQ36104839-D809DA32-04AA-4156-A506-5B131822845BQ36181880-73A8E961-D112-4DDC-9F4F-ECCB593D3A82Q36238197-DE0CE222-8DB0-4AE1-A3BB-E5BC115373F2Q36337259-2464A195-C78C-4D05-8F74-641D930AE50FQ36392412-3470D351-A697-4CF3-8631-C95CD5649678Q36557431-BF553895-E02F-4C20-AA5E-F8E616678D09Q36562344-2A0268D2-9B00-4E1B-A3F4-0C9472EE96FAQ37264652-F248501F-EEE9-4AB2-8599-1E6EAC999EF8Q37290463-CCC5F94F-DEB8-413A-9774-84A593EEED75Q37628173-947B62BA-1427-4615-A348-473C787E24DFQ37690677-94EF1DBB-437B-4D6E-940E-394830616D9CQ37694710-9C0560B8-AEAD-4168-94E1-772FEE2ED9DAQ37719554-25BC8081-BB77-4D65-BFA5-D6851E8D58AAQ38584359-40D9C2CC-2348-49D6-B3EA-844AC2037B11Q39132753-770288CD-4423-4FEA-BFBB-38060BE9B55DQ39149201-25AA2015-E821-4B1D-9D59-6D603068C643Q39157824-611C1FD0-2B81-434F-8CFA-C907AB67C986Q39425159-C26B5390-AF1A-42F2-AC28-2C1E754786C0Q40043175-2D5433B1-892A-4150-B14A-88F6C9A3AB86Q41484235-289B231F-4EBC-4CAF-93AD-F0BDD6E75893Q41505555-1FC33591-3292-4B60-9006-BC9A7ECD320EQ41620161-1D893768-8BEE-4C3A-A36A-DE70AD55B0FBQ42057245-1152001F-EA7E-4193-9B5E-081CACA9BDCEQ42335724-A416490D-6A04-434F-9224-CB93E6324E06Q42398713-CCF65DFA-428F-4859-884C-4F4242784AACQ42641203-419DC71E-4ADD-428E-AE56-89221B73CF73Q43646628-58446FA4-AD0F-4314-AB1E-46BB777EC42CQ46007270-B98C7863-2D49-460B-A254-ABA882436DE6Q47563363-C88A424B-8776-452B-809C-3488377265D5
P2860
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.
@ast
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.
@en
type
label
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.
@ast
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.
@en
prefLabel
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.
@ast
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.
@en
P2093
P2860
P356
P1476
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.
@en
P2093
Carol W M Chan
Grace L H Wong
Henry L Y Chan
K C Allen Chan
Paul B S Lai
Peiyong Jiang
Rossa W K Chiu
Stephen L Chan
Suk Hang Cheng
P2860
P304
P356
10.1073/PNAS.1500076112
P407
P577
2015-02-02T00:00:00Z